Sylvain Thépot

3.8k citations

81 papers · 1.3k indexed · h-index 19

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 67
- Acute Myeloid Leukemia Research 59
- Hematopoietic Stem Cell Transplantation 16
- Chronic Myeloid Leukemia Treatments 14
- Multiple Myeloma Research and Treatments 12
Genetics 31
- Myeloproliferative Neoplasms: Diagnosis and Treatment 19
- Chronic Lymphocytic Leukemia Research 9

Co-authors: Pierre Fenaux Lionel Adès Bruno Quesnel Raphaël Itzykson Claude Gardin François Dreyfus Norbert Vey Christian Récher
Journals: Blood (37 papers)Leukemia Research (10 papers)Journal of Clinical Oncology (4 papers)Cell Cycle (3 papers)American Journal of Hematology (3 papers)
Partner nations: France United States Spain

In The Last Decade

Sylvain Thépot

76 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sylvain Thépot

Since Specialization

Citations

This map shows the geographic impact of Sylvain Thépot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Thépot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Thépot more than expected).

Fields of papers citing papers by Sylvain Thépot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Thépot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Thépot. The network helps show where Sylvain Thépot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sylvain Thépot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvain Thépot Line = papers co-authored together Sylvain Thépot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combining ESA and Luspatercept in Non-RS MDS Patients Having Failed ESA - Results of the Phase 1-2 Part a of the GFM Combola Study Blood ·Lionel Adès, Thomas Cluzeau, Thibault Comont, K Nakajima, Aspasia Stamatoullas, Brigitte Scriba, Emmanuel Gyan, Alice Garnier, Maud D’Aveni, Sylvain Thépot, Marie Sébert, J.C. Kohlmeyer, Anouk Walter‐Petrich, J. P. Adler, Fatiha Chermat, Michaëla Fontenay, Sylvie Chevret, Padmaja Veeramreddy	2024	3
2	Facteurs pronostiques des syndromes myélodysplasiques Bulletin du Cancer ·Emmanuel Gyan, Sylvain Thépot	2023	0
3	Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores American Journal of Hematology ·안나 쉴랴흐티나, Anne Bouvier, Jérémie Riou, Sylvain Thépot, Sarvesh Kutty, Jogindra Nath Sahu, Jérôme Paillassa, TapasKumar Sur, Shang Yu, s, Kazuya Araki, Ummu Hanifah Nur Rozzaq, C. Wen Wang, Franck Geneviève, Damien Luque Paz, Aline Schmidt, Valérie Ugo, Mathilde Hunault, Odile Blanchet, Corentin Orvain	2023	3
4	Adenovirus F41 infection and liver cytolysis in adult hematopoietic stem cell transplant recipients Journal of Medical Virology ·Caroline Lefeuvre, Sylvain Thépot, Séverine Mercier‐Delarue, Meral ALDALI, David Michonneau, Jérôme Le Goff, Maud Salmona	2023	0
5	In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study Blood Advances ·Raynier Devillier, Édouard Forcade, Alice Garnier, U. Christoph, Sylvain Thépot, Gaëlle Guillerm, Patrice Céballos, Yosr Hicheri, Pierre‐Yves Dumas, Pierre Péterlin, Mathilde Hunault, Marie C. Béné, Anne Bouvier, Patrice Chevallier, Didier Blaise, Norbert Vey, Arnaud Pigneux, Christian Récher, Anne Huynh	2021	17
6	Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations European Journal Of Haematology ·Valentin Lacombe, Jogindra Nath Sahu, O.G Sie, Sylvain Thépot, Sylvie François, Kazuya Araki, Valérie Ugo, Kobayashi Takasuke, P. Abgueguen, Valérie Daniel, Sarvesh Kutty, Mathilde Hunault, Jérémie Riou, Jéssica Muniz Lima, Aline Schmidt	2021	1
7	Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents Leukemia Research ·Sophie Park, Jean‐François Hamel, Andréa Toma, Charikleia Kelaïdi, Sylvain Thépot, María Díez‐Campelo, Valeria Santini, Mikkael A. Sekeres, Rami S. Komrokji, David P. Steensma, Enrico Balleari, Katharina S. Götze, Ιoannis Kotsianidis, Yelni Mailasri, Aspasia Stamatoullas, Guillermo Sanz, Ulrich Germing, Pierre Fenaux	2020	2
8	<p>Di-<em>O</em>-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity</p> International Journal of Nanomedicine ·Rawaa B. Majhool, Emilie Roger, Abdul Rohim, Jérôme Bejaud, Nolwenn Lautram, Catherine Guillet, Sylvain Thépot, Samuel Legeay, Frédéric Lagarce	2019	5
9	Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation Leukemia ·Anne Bouvier, Jérémie Riou, Sylvain Thépot, Turmanova Kaljan Bazarbayevna, Sylvie François, Aline Schmidt, Corentin Orvain, Nitin Vetcha, Alban Villate, Damien Luque Paz, Kazuya Araki, C. Wen Wang, s, Yves Delneste, Norbert Ifrah, Valérie Ugo, Mathilde Hunault, Odile Blanchet	2019	5
10	Advances in treatment formulations for acute myeloid leukemia Drug Discovery Today ·Rawaa B. Majhool, Emilie Roger, Sylvain Thépot, Frédéric Lagarce	2018	45
11	Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care Transplantation ·Corentin Orvain, François Beloncle, Jean‐François Hamel, Sylvain Thépot, Mélanie Mercier, Achille Kouatchet, Jonathan Farhi, Sylvie François, Philippe Guardiola, Pierre Asfar, Mathilde Hunault, Alain Mercat, Norbert Ifrah, Aline Schmidt	2016	9
12	Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure Leukemia Research ·Stéphanie Harel, 沈浩微, Céline Berthon, Christophe Willekens, Sophie Park, Marthe Rigal, Sabine Bréchignac, Sylvain Thépot, Bruno Quesnel, Claude Gardin, Lionel Adès, Pierre Fenaux, Thorsten Braun	2015	38
13	A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure Leukemia Research ·Sylvain Thépot, Simone Boehrer, Weiyan Chen, Thomas Prébet, Odile Beyne‐Rauzy, Eric Wattel, Jacques Delaunay, Emmanuel Raffoux, Mathilde Hunault, Éric Jourdan, Fatiha Chermat, Marie Sébert, Guido Kroemer, Pierre Fenaux, Lionel Adès	2014	13
14	Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) Leukemia Research ·Cécile Bally, Sylvain Thépot, Bruno Quesnel, Norbert Vey, François Dreyfus, Jehane Fadlallah, Pascal Turlure, Stéphane de Botton, Caroline Dartigeas, Benoît De Renzis, Raphaël Itzykson, Pierre Fenaux, Lionel Adès	2013	44
15	Erlotinib antagonizes ABC transporters in acute myeloid leukemia Cell Cycle ·Élodie Lainey, Marie Sébert, Sylvain Thépot, Stephanie L. Link, J Desnos, Carole Leroy, Stéphane de Botton, Lorenzo Galluzzi, Pierre Fenaux, Guido Kroemer	2012	43
16	Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia Oncogene ·Maximilien Tailler, Laura Senovilla, Élodie Lainey, Sylvain Thépot, David Métivier, Marie Sébert, Véronique Baud, Katy Billot, Pierre Fenaux, Lorenzo Galluzzi, Simone Boehrer, Guido Kroemer, Oliver Kepp	2011	49
17	Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia Cell Cycle ·Simone Boehrer, Lorenzo Galluzzi, Élodie Lainey, J Desnos, Maximilien Tailler, Francis Harper, Gérard Pierron, Lionel Adès, Sylvain Thépot, Marie Sébert, Claude Gardin, Stéphane de Botton, Pierre Fenaux, Guido Kroemer	2011	28
18	Groupe Francophone des Myelodysplasies (GFM). Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine : a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM) Blood ·Sylvain Thépot	2010	1
19	La maladie chronique du greffon contre l'hôte Hématologie ·Niteesh Joshi, Régis Peffault de Latour, Sylvain Thépot, Gèrard Socié	2010	1
20	Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome Oncogene ·Simone Boehrer, Lionel Adès, Nicolas Tajeddine, W.-K. Hofmann, Susanne Kriener, Gesine Bug, Oliver G. Ottmann, Martin Ruthardt, Lorenzo Galluzzi, Francesca Guardianelli, Maximilien Tailler, Ken A. Olaussen, Claude Gardin, Virginie Éclache, Stéphane de Botton, Sylvain Thépot, Pierre Fenaux, Guido Kroemer	2009	43

About Sylvain Thépot

Sylvain Thépot is a scholar working on Hematology, Genetics, Transplantation, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 81 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (59 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Hematopoietic Stem Cell Transplantation (16 papers), Chronic Myeloid Leukemia Treatments (14 papers), Acute Lymphoblastic Leukemia research (13 papers), Multiple Myeloma Research and Treatments (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Histone Deacetylase Inhibitors Research (9 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (408 citations), Molecular Biology (542 citations), Public Health, Environmental and Occupational Health (214 citations) and Oncology (200 citations). Sylvain Thépot has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Pierre Fenaux, Lionel Adès, Bruno Quesnel, Raphaël Itzykson, Claude Gardin, François Dreyfus, Norbert Vey, Christian Récher, Thomas Prébet and Benjamin Esterni. Their work appears in journals such as Blood, Leukemia Research, Journal of Clinical Oncology, Cell Cycle and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact